Intellia Therapeutics
NTLA
$12.50
Share price
-4.65%
Change (1 day)
-53.60%
Change (1 year)
Intellia Therapeutics (NTLA) - Total debt
Total debt on the balance sheet as of March 2025 : $0.11 Billion USD
According to Intellia Therapeutics's latest financial reports the company's total debt is $0.11 Billion USD. A company’s total debt is the sum of all current and non-current debts.
Intellia Therapeutics - Total debt on balance sheet (from 2018 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | $0.21 B | 82.23% |
| 2023-12-31 | $0.11 B | -11.75% |
| 2022-12-31 | $0.13 B | 76.57% |
| 2021-12-31 | $74.02 M | 88.33% |
| 2020-12-31 | $39.3 M | 113.9% |
| 2019-12-31 | $18.37 M | |
| 2018-12-31 | N/A |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $3.21 M | -97.31% | 🇺🇸 USA |